Point72 Asia (Singapore)’s Achieve Life Sciences ACHV Stock Holding History

Point72 Asia (Singapore)’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$23.6K	Buy	+7,505	New	+$20.6K	﹤0.01%	679

Other funds holding ACHV

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Point72 Asia (Singapore)'s ACHV Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in Achieve Life Sciences (ACHV) in Q3 2025: 7,505 shares worth $23.6K. The stake represents ﹤0.01% of the portfolio and ranks #679 among its holdings.

66 funds tracked by Wall St. Rank hold ACHV as of Q3 2025.

Point72 Asia (Singapore) held 7,505 shares of Achieve Life Sciences worth $23.6K as of Q3 2025.
Achieve Life Sciences was a new Point72 Asia (Singapore) position in Q3 2025.
Achieve Life Sciences made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #679 holding.
66 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.